Presentation TCT 2014 Two-Year Clinical Results of Patients Randomized to 3- or 12-Month Dual Antiplatelet After Endeavor Zotarolimus Eluting Stent Implantation In OPTIMIZE Presenter: Fausto Feres September 16, 2014 REGISTER for free or LOG IN to view this content CAD Pharma Presentation TCT 2014 Up Next Presentation TCT 2014 Analysis of Quality of Life Decrements Associated with Changes in Angina Status in the ABSORB II Trial: First Randomized Comparison Between the Absorb? Everolimus Eluting___ Presenter: Bernard Chevalier September 16, 2014 More slides + Presentation TCT 2014 The Cost of TAVR: Association Between Length of Stay and the Cost of Transfemoral Transcatheter Aortic Valve Replacement in Medicare Patients Presenter: Christopher Meduri September 16, 2014 Presentation TCT 2014 Impact of Ischemic Post-Conditioning on Infarct Size and Clinical Outcomes in Primary Percutaneous Coronary Intervention: A Meta-analysis of 26 Randomized Controlled Trials Presenter: Alok Saurav September 16, 2014 We Recommend
Presentation TCT 2014 Analysis of Quality of Life Decrements Associated with Changes in Angina Status in the ABSORB II Trial: First Randomized Comparison Between the Absorb? Everolimus Eluting___ Presenter: Bernard Chevalier September 16, 2014
Presentation TCT 2014 The Cost of TAVR: Association Between Length of Stay and the Cost of Transfemoral Transcatheter Aortic Valve Replacement in Medicare Patients Presenter: Christopher Meduri September 16, 2014
Presentation TCT 2014 Impact of Ischemic Post-Conditioning on Infarct Size and Clinical Outcomes in Primary Percutaneous Coronary Intervention: A Meta-analysis of 26 Randomized Controlled Trials Presenter: Alok Saurav September 16, 2014